BENZIMIDAZOLE COMPOUNDS AND USE THEREOF FOR TREATING ALZHEIMER'S DISEASE OR HUNTINGTON'S DISEASE
申请人:National Health Research Institutes
公开号:US20200071312A1
公开(公告)日:2020-03-05
Benzimidazole compounds of formula (I), shown below, are disclosed. The compounds are potent human glutaminyl cyclase inhibitors. Also disclosed is a pharmaceutical composition containing one of these compounds and a pharmaceutical acceptable carrier, as well as a method of treating Alzheimer's disease or Huntington's disease by administering to a subject in need thereof an effective amount of such a compound.
以下显示的化学式(I)的苯并咪唑化合物已被披露。这些化合物是强效的人类谷氨酰环化酶抑制剂。还披露了一种含有其中一种这些化合物和一种药用可接受载体的药物组合物,以及通过向需要的受试者施用这种化合物的有效量来治疗阿尔茨海默病或亨廷顿病的方法。